Correlation Between Skandinaviska Enskilda and Bio Works

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Skandinaviska Enskilda and Bio Works at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Skandinaviska Enskilda and Bio Works into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Skandinaviska Enskilda Banken and Bio Works Technologies AB, you can compare the effects of market volatilities on Skandinaviska Enskilda and Bio Works and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Skandinaviska Enskilda with a short position of Bio Works. Check out your portfolio center. Please also check ongoing floating volatility patterns of Skandinaviska Enskilda and Bio Works.

Diversification Opportunities for Skandinaviska Enskilda and Bio Works

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Skandinaviska and Bio is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Skandinaviska Enskilda Banken and Bio Works Technologies AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Works Technologies and Skandinaviska Enskilda is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Skandinaviska Enskilda Banken are associated (or correlated) with Bio Works. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Works Technologies has no effect on the direction of Skandinaviska Enskilda i.e., Skandinaviska Enskilda and Bio Works go up and down completely randomly.

Pair Corralation between Skandinaviska Enskilda and Bio Works

Assuming the 90 days trading horizon Skandinaviska Enskilda Banken is expected to under-perform the Bio Works. But the stock apears to be less risky and, when comparing its historical volatility, Skandinaviska Enskilda Banken is 4.43 times less risky than Bio Works. The stock trades about -0.1 of its potential returns per unit of risk. The Bio Works Technologies AB is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  83.00  in Bio Works Technologies AB on August 29, 2024 and sell it today you would earn a total of  1.00  from holding Bio Works Technologies AB or generate 1.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Skandinaviska Enskilda Banken  vs.  Bio Works Technologies AB

 Performance 
       Timeline  
Skandinaviska Enskilda 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Skandinaviska Enskilda Banken has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Bio Works Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bio Works Technologies AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Skandinaviska Enskilda and Bio Works Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Skandinaviska Enskilda and Bio Works

The main advantage of trading using opposite Skandinaviska Enskilda and Bio Works positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Skandinaviska Enskilda position performs unexpectedly, Bio Works can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Works will offset losses from the drop in Bio Works' long position.
The idea behind Skandinaviska Enskilda Banken and Bio Works Technologies AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance